Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease

Camilla Filoni, Anna Caciotti, Laura Carraresi, Maria Alice Donati, Renzo Mignani, Rossella Parini, Mirella Filocamo, Fausto Soliani, Lisa Simi, Renzo Guerrini, Enrico Zammarchi, Amelia Morrone

Research output: Contribution to journalArticle

Abstract

Total or partial deficiency of the human lysosomal hydrolase α-galactosidase A is responsible for Fabry disease, the X-linked inborn error of glycosphingolipid metabolism. Together with the predominant α-galactosidase A gene mRNA product encoding the lysosomal enzyme, a weakly regulated alternatively spliced α-galactosidase A transcript is expressed in normal tissues, but its overexpression, due to the intronic g.9331G > A mutation, leads to the cardiac variant. We report the molecular characterization of five Fabry patients including two siblings. Sequencing analysis of the α-galactosidase A gene coding region and intron/exon boundaries identified the new c.124A > G (p.M42V) genetic lesion as well as a known deletion in three patients, whereas in the two remaining patients, no mutations were identified. To evaluate possible α-galactosidase A gene transcription alterations, both predominant and alternatively spliced mRNAs were quantified by absolute real-time PCR on total RNA preparations from the patients' fibroblasts. An impressive reduction in the predominant α-galactosidase A transcript was detected in the last patients (Pt 4 and Pt 5). However, the alternatively spliced mRNA was dramatically overexpressed in one of them, carrying a new intronic lesion (g.9273C>T). These findings strongly suggest a correlation between this new intronic mutation and the unbalanced α-galactosidase A mRNAs ratio, which could therefore be responsible for the reduced enzyme activity causing Fabry disease. The real-time assay developed here to investigate the two α-galactosidase A mRNAs might play a crucial role in revealing possible genetic lesions and in confirming the pathogenetic mechanisms underlying Fabry disease.

Original languageEnglish
Pages (from-to)1311-1317
Number of pages7
JournalEuropean Journal of Human Genetics
Volume16
Issue number11
DOIs
Publication statusPublished - 2008

ASJC Scopus subject areas

  • Genetics(clinical)
  • Genetics

Fingerprint Dive into the research topics of 'Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease'. Together they form a unique fingerprint.

  • Cite this

    Filoni, C., Caciotti, A., Carraresi, L., Donati, M. A., Mignani, R., Parini, R., Filocamo, M., Soliani, F., Simi, L., Guerrini, R., Zammarchi, E., & Morrone, A. (2008). Unbalanced GLA mRNAs ratio quantified by real-time PCR in Fabry patients' fibroblasts results in Fabry disease. European Journal of Human Genetics, 16(11), 1311-1317. https://doi.org/10.1038/ejhg.2008.109